Nicholas A. Vitanza

Immunotherapy for brain tumors: understanding early successes and limitations.

Characterization of the immune microenvironment of diffuse intrinsic pontine glioma: implications for development of immunotherapy.

Diffuse Intrinsic Pontine Glioma: From Diagnosis to Next-Generation Clinical Trials.

EGFR806-CAR T cells selectively target a tumor-restricted EGFR epitope in glioblastoma.

Children with DIPG and high-grade glioma treated with temozolomide, irinotecan, and bevacizumab: the Seattle Children's Hospital experience.

Optimal therapeutic targeting by HDAC inhibition in biopsy-derived treatment-naïve diffuse midline glioma models.

Considerations when treating high-grade pediatric glioma patients with immunotherapy.

MRI-based radiomics for prognosis of pediatric diffuse intrinsic pontine glioma: an international study.

Locoregional infusion of HER2-specific CAR T cells in children and young adults with recurrent or refractory CNS tumors: an interim analysis.

Pharmaco-proteogenomic profiling of pediatric diffuse midline glioma to inform future treatment strategies.

Preclinical and clinical evaluation of German-sourced ONC201 for the treatment of H3K27M-mutant diffuse intrinsic pontine glioma.

Two cases of pineal anlage tumor with molecular analysis.

Serial H3K27M cell-free tumor DNA (cf-tDNA) tracking predicts ONC201 treatment response and progression in diffuse midline glioma.

Imipridones affect tumor bioenergetics and promote cell lineage differentiation in diffuse midline gliomas.

The intrinsic and microenvironmental features of diffuse midline glioma: Implications for the development of effective immunotherapeutic treatment strategies.

Intraventricular B7-H3 CAR T Cells for Diffuse Intrinsic Pontine Glioma: Preliminary First-in-Human Bioactivity and Safety.

Phase I dose escalation and expansion trial of single agent ONC201 in pediatric diffuse midline gliomas following radiotherapy.

Locoregional CAR T cells for children with CNS tumors: Clinical procedure and catheter safety.

Functional genomic analysis of adult and pediatric brain tumor isolates.